The CAIX inhibitor SLC-0111 exerts anti-cancer activity on gastric cancer cell lines and resensitizes resistant cells to 5-Fluorouracil, taxane-derived, and platinum-based drugs.
Andreucci E, Biagioni A, Peri S, Versienti G, Cianchi F, Staderini F, Antonuzzo L, Supuran CT, Olivo E, Pasqualini E, Messerini L, Massi D, Lulli M, Ruzzolini J, Peppicelli S, Bianchini F, Schiavone N, Calorini L, Magnelli L, Papucci L.
Andreucci E, et al. Among authors: massi d.
Cancer Lett. 2023 Sep 1;571:216338. doi: 10.1016/j.canlet.2023.216338. Epub 2023 Aug 6.
Cancer Lett. 2023.
PMID: 37549770